Sudha Shyama Prem, Seenisamy R, Bharadhwaj K
Department of Radiotherapy, JIPMER, Puducherry, India.
J Cancer Res Ther. 2018 Jul-Sep;14(5):1005-1009. doi: 10.4103/0973-1482.189400.
Our study was undertaken to compare the dosimetric parameters of volumetric modulated arc therapy (VMAT) and three-dimensional conformal radiotherapy (3DCRT) in postmastectomy patients with left-sided carcinoma breast.
This was a hospital-based cross-sectional study.
Thirty plans were generated - VMAT with two partial arcs and field in field tangential 3DCRT plans.
In the 3DCRT plans, planning target volume (PTV) dose coverage was 2% higher compared with the VMAT plan 98.21 ± 1.79 versus 96.30 ± 2.62 (P = 0.028). The conformity index was better for the 3DCRT plan (0.97 vs. 0.95; P = 0.022), while the homogeneity index was worse for the VMAT plans (0.16 vs. 0.23; P = 0.057). However, the organ at risk sparing was better with the VMAT plans when compared to the 3DCRT plans. This was particularly relevant for the higher doses. The V20 Gy (34.94 vs. 24.42), V30 Gy (32.32 vs. 16.19), and V40 Gy (28.23 vs. 8.03) for the lung were significantly higher for the 3DCRT plans when compared to VMAT plans (P = 0.000). Similarly, the V20 Gy (29.88 vs. 12.79), V30 Gy (27.25 vs. 4.94), and V40 Gy (24.58 vs. 1.47) for the heart was significantly higher for the 3DCRT plans when compared to the VMAT plans (P = 0.000). The V5 Gy for lung (77.86 vs. 47.38) and heart (76.18 vs. 39.36) was significantly higher for the VMAT plans when compared to the 3DCRT plans (P = 0.000).
VMAT is dosimetrically superior to the field-in-field 3DCRT for left-sided breast cancer patients owing to its comparable PTV coverage and better sparing of heart and lung.
我们开展这项研究旨在比较左侧乳腺癌乳房切除术后患者容积调强弧形放疗(VMAT)和三维适形放疗(3DCRT)的剂量学参数。
这是一项基于医院的横断面研究。
生成了30个计划——两个部分弧形的VMAT计划和野中野切线3DCRT计划。
在3DCRT计划中,计划靶体积(PTV)剂量覆盖比VMAT计划高2%,分别为98.21±1.79与96.30±2.62(P = 0.028)。3DCRT计划的适形指数更好(0.97对0.95;P = 0.022),而VMAT计划的均匀性指数更差(0.16对0.23;P = 0.057)。然而,与3DCRT计划相比,VMAT计划对危及器官的保护更好。这在高剂量时尤为明显。与VMAT计划相比,3DCRT计划中肺的V20 Gy(34.94对24.42)、V30 Gy(32.32对16.19)和V40 Gy(28.23对8.03)显著更高(P = 0.000)。同样,与VMAT计划相比,3DCRT计划中心脏的V20 Gy(29.88对12.79)、V30 Gy(27.25对4.94)和V40 Gy(24.58对1.47)显著更高(P = 0.000)。与3DCRT计划相比,VMAT计划中肺的V5 Gy(77.86对47.38)和心脏的V5 Gy(76.18对39.36)显著更高(P = 0.000)。
对于左侧乳腺癌患者,VMAT在剂量学上优于野中野3DCRT,因为其PTV覆盖相当且对心脏和肺的保护更好。